Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Renal Division, Westmead Hospital, Westmead, New South Wales, Australia.
FASEB J. 2019 Nov;33(11):12735-12749. doi: 10.1096/fj.201900120RR. Epub 2019 Aug 31.
Acute kidney injury (AKI) initiates a complex pathophysiological cascade leading to epithelial cell death. Recent studies identify autophagy, a key intracellular process that degrades cytoplasmic constituents, as protective against AKI. We have previously reported that the protein thrombospondin-1 and its receptor CD47 are induced in AKI; however, the mechanism underlying their regulation of injury is unknown. Here, we investigated whether CD47 signaling affects autophagy to regulate AKI. Wild-type (WT) and CD47 mice were challenged with renal ischemia-reperfusion injury. All animals underwent analysis of renal function and biomolecular phenotyping. CD47 mice were resistant to AKI, with decreased serum creatinine and ameliorated histologic changes compared with WT animals. These mice also displayed increased abundance of key autophagy genes, including autophagy-related gene (Atg)5, Atg7, beclin-1, and microtubule-associated proteins 1A/1B light chain 3 (LC3) at baseline and post-AKI, which were significantly reduced in WT mice. Changes in protein expression correlated with increased autophagosome and autolysosome formation in renal tubular epithelial cells (RTECs). In mouse kidney transplantation, treatment with a CD47-blocking antibody that improved function was associated with increased autophagy compared with control mice. Primary isolated RTECs from CD47 mice demonstrated increased basal expression of several autophagy components that was preserved under hypoxic stress. These data suggest that activated CD47 promotes AKI through inhibition of autophagy and point to CD47 as a target to preserve renal function following injury.-El-Rashid, M., Ghimire, K., Sanganeria, B., Lu, B., Rogers, N. M. CD47 limits autophagy to promote acute kidney injury.
急性肾损伤(AKI)引发复杂的病理生理级联反应,导致上皮细胞死亡。最近的研究表明,自噬是一种关键的细胞内过程,可降解细胞质成分,对 AKI 具有保护作用。我们之前曾报道过,血小板反应蛋白-1(TSP-1)及其受体 CD47 在 AKI 中被诱导;然而,其调节损伤的机制尚不清楚。在这里,我们研究了 CD47 信号是否影响自噬来调节 AKI。野生型(WT)和 CD47 小鼠接受肾缺血再灌注损伤的挑战。所有动物均进行肾功能和生物分子表型分析。与 WT 动物相比,CD47 小鼠对 AKI 具有抗性,血清肌酐降低,组织学变化改善。这些小鼠还显示出关键自噬基因的丰度增加,包括自噬相关基因(Atg)5、Atg7、beclin-1 和微管相关蛋白 1A/1B 轻链 3(LC3),在 AKI 前后均增加,而 WT 小鼠则显著减少。蛋白表达的变化与肾小管上皮细胞(RTEC)中自噬体和自噬溶酶体形成的增加相关。在小鼠肾移植中,改善功能的 CD47 阻断抗体治疗与对照小鼠相比,自噬增加。与 WT 相比,CD47 小鼠的原代分离 RTEC 显示几种自噬成分的基础表达增加,在缺氧应激下仍能保留。这些数据表明,激活的 CD47 通过抑制自噬促进 AKI,并表明 CD47 是损伤后保留肾功能的靶点。